Skip to content

Earnings yield at other companies

AMN Healthcare logo
AMN HealthcareAMN
-4.6%-1.9pp
Teladoc Health logo
Teladoc HealthTDOC
-17.6%-7.6pp
Cencora logo
CencoraCOR
3.3%-0.8pp
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
4.9%+1.2pp
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
4.2%-0.1pp
Concentra Group Holdings Parent logo
Concentra Group Holdings ParentCON
6.5%+0.8pp

Other financials

Income statement

See full
Revenue$241.1M-17.8%
Operating income-$4.2M-325%
Net income-$4.3M-771%
EPS (diluted)-$0.14-600%

Balance sheet

See full
Cash & equivalents$105.6M+30.8%
Total debt$2.0M-38.3%
Total equity$312.8M-25.2%
Total assets$451.1M-21.7%

Cash flow

See full
Operating cash flow$4.8M-16.1%
CapEx$1.5M-22.7%
Free cash flow$3.3M-12.8%

Valuation

See full
Market cap$426.12M-6.5%
Enterprise value$322.58M-14.7%
P/S0.4×+0.1×

Profitability

See full
Operating margin-8.7%-11.4pp
Net margin-9.8%-11.8pp
FCF margin4%-4.9pp

Returns & leverage

See full
Return on equity-27%-32.7pp
Debt / equity0.0×
Current ratio3.3×+0.3×

Where this comes from

Calculated from Cross Country Healthcare’s reported figures.

Based on trailing twelve months.

The official record: Cross Country Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cross Country Healthcare's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cross Country Healthcare's earnings yield?
Cross Country Healthcare (CCRN) reported earnings yield of -32.5% in Q1 2026.
How has Cross Country Healthcare's earnings yield changed year-over-year?
Cross Country Healthcare's earnings yield decreased by 794.2% year-over-year, from -3.6% to -32.5%.
What is the long-term trend for Cross Country Healthcare's earnings yield?
Over 5 years (2020 to 2025), Cross Country Healthcare's earnings yield has grown at a 56.2% compound annual growth rate (CAGR), from -3.8% to -35.7%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.